Fall 2015

After a rigorous scientific review, MD Anderson's Moon Shots Program is zeroing in on six additional areas of focus: b-cell lymphomas, colorectal cancer, glioblastoma, high-risk multiple myeloma, human papillomavirus-related cancers and pancreatic cancer.

Mel Klein has been a member of the MD Anderson Cancer Center Board of Visitors for 25 years and is currently serving his second year as chair. An investment banker, entrepreneur, venture capitalist, attorney and philanthropist, he is the founder of Melvyn N. Klein Interests and a respected community leader in Corpus Christi, Texas, with business interests in New York, Chicago, Los Angeles and other cities in the U.S. and internationally. From 1980 to 2005, he wrote the guest column "Feedback" for the Corpus Christi Caller-Times, later compiled in the book "Our Time," proceeds of which benefit MD Anderson. In 1996, he was named to the Horatio Alger Association of Distinguished Americans. Klein and his wife, Annette, are members of the Anderson Assembly, an organization honoring donors who've made lifetime commitments of $1 million or more to MD Anderson. They have two daughters, Jacqueline and Jenna.

Rosemary Herron is a 14-year breast cancer survivor and longtime Pink Ribbon Volunteer at MD Anderson's Nellie B. Connally Breast Center. She also volunteers at MD Anderson in Sugar Land. In 2012, she received the Painter Award for outstanding contributions to the Anderson Network support group, now known as myCancerConnection. Though her breast cancer returned two months later, she continued volunteering throughout treatment. Rosemary and her husband Don, recently contributed $25,000 to support a HER2 vaccine research program, Injecting Hope. The program is led by Elizabeth Mittendorf, M.D., associate professor, Breast Surgical Oncology.

Thoughtful investigation and steady perseverance are the approaches MD Anderson's specialists use to unlock answers to cancer's mysteries. They're also the tactics behind Colin Chopin's history as a 30-year Annual Fund supporter.

Catherine and Ben Ivy were married only five years before cancer uprooted their entire world.

Summer seminars spread prevention tips cross-country

Inaugural impact luncheon honors Tom Buchholz, M.D.

For the first time, an immune checkpoint inhibitor has been proven to increase survival among patients with advanced renal cell carcinoma (RCC), for whom treatment options are limited.

Ronald DePinho, M.D. has been named to Modern Healthcare's 2015 list of Top 100 Most Influential People in Healthcare.

Five globetrotting, sun-blocking superheroes use their superpowers - shade, clothing, sunscreen, hats and sunglasses - to teach preschoolers about lifelong sun safety.